These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 18582952

  • 21. Antibody response in MOG(35-55) induced EAE.
    Lalive PH, Molnarfi N, Benkhoucha M, Weber MS, Santiago-Raber ML.
    J Neuroimmunol; 2011 Dec 15; 240-241():28-33. PubMed ID: 21993076
    [Abstract] [Full Text] [Related]

  • 22. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.
    Morini M, Roccatagliata L, Dell'Eva R, Pedemonte E, Furlan R, Minghelli S, Giunti D, Pfeffer U, Marchese M, Noonan D, Mancardi G, Albini A, Uccelli A.
    J Neuroimmunol; 2004 Mar 15; 148(1-2):146-53. PubMed ID: 14975595
    [Abstract] [Full Text] [Related]

  • 23. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R, Cadenas V, Lozano M, Almonacid L, Zaballos A, Martínez-A C, Varona R.
    Eur J Immunol; 2009 Jun 15; 39(6):1671-81. PubMed ID: 19499521
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis.
    Guo X, Nakamura K, Kohyama K, Harada C, Behanna HA, Watterson DM, Matsumoto Y, Harada T.
    Neurosci Res; 2007 Dec 15; 59(4):457-66. PubMed ID: 17920148
    [Abstract] [Full Text] [Related]

  • 25. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.
    Rich C, Link JM, Zamora A, Jacobsen H, Meza-Romero R, Offner H, Jones R, Burrows GG, Fugger L, Vandenbark AA.
    Eur J Immunol; 2004 May 15; 34(5):1251-61. PubMed ID: 15114658
    [Abstract] [Full Text] [Related]

  • 26. The human CMV-UL86 peptide 981-1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34-56, but lacks the capacity to induce EAE in rhesus monkeys.
    Brok HP, Boven L, van Meurs M, Kerlero de Rosbo N, Celebi-Paul L, Kap YS, Jagessar A, Hintzen RQ, Keir G, Bajramovic J, Ben-Nun A, Bauer J, Laman JD, Amor S, 't Hart BA.
    J Neuroimmunol; 2007 Jan 15; 182(1-2):135-52. PubMed ID: 17126916
    [Abstract] [Full Text] [Related]

  • 27. Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis.
    Thessen Hedreul M, Gillett A, Olsson T, Jagodic M, Harris RA.
    J Neuroimmunol; 2009 May 29; 210(1-2):30-9. PubMed ID: 19269041
    [Abstract] [Full Text] [Related]

  • 28. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
    Black JA, Liu S, Hains BC, Saab CY, Waxman SG.
    Brain; 2006 Dec 29; 129(Pt 12):3196-208. PubMed ID: 16931536
    [Abstract] [Full Text] [Related]

  • 29. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L, Gonzalez Deniselle MC, Gierman L, Meyer M, Lima A, Roig P, De Nicola AF.
    Neuroimmunomodulation; 2008 Dec 29; 15(1):76-83. PubMed ID: 18667803
    [Abstract] [Full Text] [Related]

  • 30. Copper/zinc chelation by clioquinol reduces spinal cord white matter damage and behavioral deficits in a murine MOG-induced multiple sclerosis model.
    Choi BY, Jang BG, Kim JH, Seo JN, Wu G, Sohn M, Chung TN, Suh SW.
    Neurobiol Dis; 2013 Jun 29; 54():382-91. PubMed ID: 23360710
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
    Ellestad KK, Tsutsui S, Noorbakhsh F, Warren KG, Yong VW, Pittman QJ, Power C.
    J Immunol; 2009 Jul 01; 183(1):298-309. PubMed ID: 19542441
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis.
    Raikwar HP, Muthian G, Rajasingh J, Johnson C, Bright JJ.
    J Neuroimmunol; 2005 Oct 01; 167(1-2):99-107. PubMed ID: 16091293
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.